Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19.
Huang J, Ding Y, Yao J, Zhang M, Zhang Y, Xie Z, Zuo J.
Huang J, et al. Among authors: zhang m, zhang y.
Vaccines (Basel). 2022 Mar 8;10(3):405. doi: 10.3390/vaccines10030405.
Vaccines (Basel). 2022.
PMID: 35335037
Free PMC article.
Review.